Somru BioScience is a leading bioanalytical Contract Research Organization (CRO) specializing in large molecule therapeutics. With a commitment to innovation and excellence, we provide comprehensive GxP-compliant bioanalytical services that leverage cutting-edge technologies and solutions.

Our proprietary fingerprinting technology enables precise bio-similarity assessments of molecules, while our advanced immunoassay platforms deliver unparalleled sensitivity, detecting analytes at the attomolar level. Backed by profound scientific expertise and regulatory knowledge, we develop robust and novel bioanalytical methods, including molecular assays, immunoassays, and cell-based assays. These methodologies support biodistribution, safety, efficacy, and immunogenicity studies for pioneering cell and gene therapies and other large molecule candidates.

In addition to our CRO services, we offer an extensive portfolio of high-quality reagents tailored for research, diagnostics, and biosimilar development. At Somru BioScience, we are dedicated to driving innovation, ensuring compliance, and delivering impactful results to advance the next generation of therapeutic breakthroughs.